Most testosterone replacement therapy comes with a hidden cost: it can shut down your own sperm production. For a man who still wants kids, that trade-off is a deal-breaker. Natesto, a nasal testosterone gel, is the one TRT product built to sidestep that problem. It raises testosterone while keeping the hormones that drive sperm production switched on.
This guide explains how Natesto works, what the clinical trials actually show, who it fits, and where it falls short. We stick to the FDA label and peer-reviewed studies, and we flag the gaps honestly.
Medical disclaimer: This article is for education only. It is not medical advice and does not replace a conversation with a licensed clinician. Testosterone is a controlled substance (Schedule III). Do not start, stop, or change any therapy without a doctor who can order labs and monitor you.
Quick Answer
- What it is: Natesto is a nasal testosterone gel you pump into each nostril three times a day. Each pump delivers 5.5 mg, and the standard dose is 11 mg three times daily (33 mg total), per the FDA label.
- Why it's "fertility-friendly": It is short-acting. Testosterone peaks about 40 minutes after a dose and clears within a few hours, so it does not flood the brain around the clock. That lets the pituitary keep releasing LH and FSH, the signals that keep sperm production running.
- What the evidence shows: In a Phase IV trial of 60 hypogonadal men, semen parameters stayed unchanged at 3 and 6 months, and LH and FSH stayed in the normal range. Only 1 man (2.5%) became azoospermic, and he recovered after stopping (Ramasamy 2020, PMID 32294396). By contrast, standard TRT causes azoospermia in up to 65% of men.
- The catch: Three-times-a-day dosing, frequent nasal irritation, a high cash price (often around $1,000/month before coupons), and a label limited to diagnosed hypogonadism, not "low T from aging."
What Is Natesto and How Is It Different From Other TRT?
Natesto is a gel form of testosterone you apply inside your nose. The FDA approved it in 2014. The active ingredient is the same bioidentical testosterone found in injections, creams, and patches. What's different is the route and, more importantly, the timing.
Other TRT formats are built to last. A testosterone cypionate injection holds levels up for a week or more. A pellet under the skin releases hormone for three to six months. A daily gel on your shoulders keeps blood levels steady all day. Steady sounds good, but for sperm production it's a trap. Constant testosterone in the blood tells the brain to stop sending its own signals.
Natesto flips that. Because it absorbs through the nasal lining and clears fast, it creates short bursts of testosterone rather than a flat 24-hour plateau. Testosterone rises within an hour or two and falls a few hours later. Those gaps between doses are the whole point.
| Feature | Natesto (nasal gel) | Injections (cypionate/enanthate) | Daily gel/cream | Pellets |
|---|---|---|---|---|
| Dosing frequency | 3x daily | Every 3.5–7 days | Once daily | Every 3–6 months |
| Half-life profile | Short, pulsatile | Long, steady | Steady all day | Very long, steady |
| Typical effect on sperm | Largely preserved | Suppressed (azoospermia up to 65%) | Suppressed | Strongly suppressed |
| Risk of transference to others | Very low | None | Moderate (skin contact) | None |
| Hematocrit rise | Lower (short exposure) | Higher | Moderate | Moderate |
| FDA fertility claim | No formal fertility claim | No | No | No |
For a full side-by-side of the delivery options, see our guide on TRT delivery methods: injections vs cream vs pellets vs nasal.
Why Does Regular TRT Shut Down Sperm Production?
To get why Natesto is special, you need to understand the chain of command that runs male fertility. It's called the hypothalamic-pituitary-gonadal (HPG) axis.
It works like a thermostat. The hypothalamus in your brain releases GnRH in pulses. Those pulses tell the pituitary gland to release two hormones: luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH tells the testes to make testosterone. FSH, working alongside that local testosterone, drives sperm production.
Here's the key fact most men don't know. The testosterone inside the testes, called intratesticular testosterone, sits at levels roughly 50 to 100 times higher than what's in your blood. Sperm need that local concentration to mature. You cannot reach it with a pill or a shot.
When you put exogenous testosterone into your blood, the brain senses plenty of testosterone and stops sending GnRH pulses. LH and FSH fall. The testes stop making their own testosterone, intratesticular levels crash, and sperm production stalls. A 2005 study by Coviello and colleagues showed that suppressing gonadotropins drops intratesticular testosterone dramatically, and that low-dose HCG can hold it up (Coviello 2005, PMID 15713727).
The downstream result is well documented. A 2025 clinical review notes that exogenous testosterone and anabolic steroids suppress the HPG axis, slash intratesticular testosterone, and impair sperm production, with azoospermia (zero sperm in the ejaculate) common (Hashimi 2025, PMID 39820213). Long-acting testosterone undecanoate has produced azoospermia in 93% to 99% of men in trials. This is so reliable that testosterone was once studied as a male contraceptive.
If you want the deeper mechanism and the fertility-preservation toolkit, read our companion guide on TRT and fertility: HCG and enclomiphene explained.
How Does Natesto Preserve Fertility?
The answer is timing, not magic. Natesto uses the exact same testosterone as everything else. The difference is that it never stays in the blood long enough to fully silence the brain.
Pharmacokinetic data show testosterone from Natesto peaks roughly 40 minutes after a dose, then falls back over the next few hours. Dosed three times a day at least 6 to 8 hours apart, it creates a sawtooth pattern of short peaks and valleys. During the valleys, the hypothalamus resumes its GnRH pulses, and the pituitary keeps releasing LH and FSH. That preserved signaling keeps the testes working, which keeps intratesticular testosterone and sperm production going.
This is a more physiologic mimic of how a healthy young man's testosterone behaves. Natural testosterone is pulsatile, not flat. Long-acting TRT smooths the curve into a plateau that the brain reads as "we have enough, shut it down." Natesto keeps the rhythm.
The clinical data back the mechanism. In the Phase IV trial, LH and FSH dropped slightly but stayed inside the normal reference range rather than crashing to zero (Ramasamy 2020, PMID 32294396). That partial preservation is the difference between keeping and losing your sperm count.
What the Phase IV Trial Showed
The pivotal investigator-initiated study was run at the University of Miami. Hypogonadal men aged 19 to 55 with confirmed low testosterone and a baseline sperm count were treated with Natesto for up to 6 months.
| Outcome | Baseline | At 3 and 6 months |
|---|---|---|
| Total testosterone | Hypogonadal (<300 ng/dL by entry) | Rose into normal range (p=0.005) |
| LH | Normal | Decreased but stayed in normal range (p=0.03) |
| FSH | Normal | Decreased but stayed in normal range (p=0.03) |
| Semen parameters | Normal (entry requirement) | Unchanged |
| Intratesticular testosterone (via 17-OHP) | — | Maintained |
| Testicular volume | — | Stable |
Out of 60 men, 3 (7.5%) developed severe oligospermia (very low count) and 1 (2.5%) became azoospermic, but that man recovered sperm production after stopping the drug (Ramasamy 2020, PMID 32294396). An earlier interim report from the same program reached the same conclusion: Natesto raised testosterone, improved symptoms, and preserved gonadotropins and semen parameters (Masterson 2018, PMID 30177402).
Across the reported data, roughly 90% to 95% of men maintained semen parameters in the normal range. Compare that to up to 65% becoming azoospermic on standard TRT, and the fertility advantage is clear.
One honest caveat: these were small, single-center, open-label trials without a head-to-head comparison against injections. The signal is consistent and biologically sound, but it's not the same as a large randomized trial. The FDA label does not carry a formal fertility-preservation claim.
Who Is Natesto a Good Fit For?
Natesto isn't for everyone on TRT. It shines for a specific patient.
Good candidates:
- Men with diagnosed hypogonadism who want to father children now or keep that door open.
- Younger men (the trials enrolled men 19 to 55) with secondary hypogonadism who would otherwise risk losing fertility on standard TRT.
- Men who can't or won't use a transferable topical gel because they have young kids or a pregnant partner at home. Nasal application means almost no skin-to-skin transfer risk.
- Men who want lower hematocrit risk. Short testosterone exposure tends to raise red blood cells less than long-acting forms. (See high hematocrit on TRT.)
Poor candidates:
- Men who hate the idea of dosing three times every single day. Adherence is the Achilles' heel.
- Men with chronic sinus problems, nasal polyps, prior nasal surgery, or severe allergies. The FDA label warns against use in these cases.
- Men seeking "low T" treatment purely for aging. The label states safety and efficacy in "age-related hypogonadism" have not been established.
- Men who want a fully suppressed, set-and-forget protocol with minimal touches.
It's worth knowing Natesto is not the only fertility-sparing path. For some men, the better move is to never use exogenous testosterone at all and instead restart their own production. That's where enclomiphene comes in. A 2016 study found oral enclomiphene citrate raised testosterone while preserving sperm counts, unlike topical testosterone, which suppressed them, the authors framed it as "restoration instead of replacement" (Kim 2016, PMID 26496621). Our deep dive on enclomiphene vs TRT walks through that choice.
How Do You Use Natesto Correctly?
The dosing is simple to describe but demanding to keep up.
| Detail | Specification |
|---|---|
| Dose per pump | 5.5 mg testosterone |
| Standard dose | 11 mg (1 pump per nostril) |
| Frequency | 3 times daily |
| Total daily dose | 33 mg |
| Spacing | At least 6–8 hours apart (e.g., morning, midday, evening) |
| Schedule (controlled substance) | Schedule III |
Source: Natesto FDA prescribing information.
A few practical rules from the label:
- Blow your nose first, then prime the pump as directed before the first use.
- Don't sniff or blow your nose for about an hour after dosing, that's the absorption window.
- Avoid nasal decongestant sprays. The label found that allergic rhinitis reduced testosterone absorption by 21% to 24%. Oxymetazoline had minimal effect, but check with your clinician before mixing in any nasal product.
- If you get a bad cold or severe rhinitis, the label advises pausing Natesto until your nasal passages clear.
Three doses a day is a real lifestyle ask. Miss the midday dose at work often enough and your levels, and your symptom control, suffer. Be honest with yourself about adherence before you commit.
What Are the Side Effects and Risks?
Most side effects are local and minor, but they're common enough that some men quit over them.
| Side effect | Notes |
|---|---|
| Nasal irritation / discomfort | Most common; a leading reason for dropout in trials |
| Runny nose, nosebleed, nasal scabbing | Local effects from repeated application |
| Headache | Reported in trials |
| Temporary oligospermia/azoospermia | Uncommon; reversible after stopping in trial data |
| Increased PSA | Class effect of all TRT; monitor |
| Mood or libido changes | Possible with any testosterone therapy |
In the Phase IV trial, nasal irritation drove a meaningful share of the 17 dropouts out of 60 enrolled men (Ramasamy 2020, PMID 32294396). That dropout rate is the real-world cost of nasal dosing.
The standard TRT safety topics still apply. You should monitor hematocrit, PSA, and estradiol on any testosterone therapy. The good news is that Natesto's short exposure profile tends to push hematocrit and estradiol up less than long-acting injections do, which can mean fewer issues with thick blood or high estrogen. For the broader picture, read TRT side effects and safety and our take on estrogen management on TRT.
Contraindications from the FDA label: known or suspected prostate cancer, breast cancer in men, and it's not for use by women, especially during pregnancy. Men with significant nasal disease should avoid it.
How Does Natesto Compare to HCG and Enclomiphene for Fertility?
Natesto isn't the only way to keep TRT from torpedoing your fertility. The three main fertility-friendly strategies attack the problem from different angles.
| Approach | How it preserves fertility | Form | Best for |
|---|---|---|---|
| Natesto | Short-acting testosterone leaves gaps so the pituitary keeps signaling | Nasal gel, 3x daily | Men who want true testosterone but need to protect sperm |
| HCG add-on | Mimics LH, directly stimulates testes to keep intratesticular testosterone high | Injection, often alongside TRT | Men on standard TRT who want to keep sperm production |
| Enclomiphene | Blocks estrogen feedback at the brain, raises the body's own LH/FSH | Oral pill | Men who want to boost their own testosterone, not replace it |
The HCG evidence is solid. A 2013 study found that concomitant low-dose intramuscular HCG preserved spermatogenesis in men on testosterone replacement (Hsieh 2013, PMID 23260550). That's why many fertility-minded men on injections add HCG.
Enclomiphene takes a different road. It doesn't add testosterone at all, it convinces your brain to make more of its own, which keeps the whole axis intact (Kim 2016, PMID 26496621).
So which wins? It depends on goals. If you want the proven feel of real testosterone but need to protect sperm, Natesto is uniquely positioned. If you're already committed to injections, HCG is the add-on. If you want to avoid exogenous testosterone entirely, enclomiphene may fit. Many clinicians mix and match. A full comparison lives at TRT and fertility: HCG and enclomiphene explained, and you can line up your options on our compare page.
What Does Natesto Cost and Is It Covered?
Natesto is one of the pricier TRT options. The average cash retail price runs around $1,000 or more for a monthly supply, which makes it far more expensive than a vial of testosterone cypionate that can cost $20 to $40 a month.
| Pricing path | Typical cost | Notes |
|---|---|---|
| Average cash retail | ~$1,000+/month | Before any discount |
| GoodRx coupon | ~$165/month (varies) | Discount card, no insurance needed |
| Manufacturer savings card | As low as $0 (commercial insurance) | Eligibility and annual caps apply |
| Cash option program | ~$140 per 30-day fill (varies) | For uninsured patients |
| Commercial insurance | Varies | Often needs prior authorization |
Prices change and vary by pharmacy and region. Always check current numbers on GoodRx and ask your pharmacy. Insurance coverage is inconsistent because Natesto is a branded product with no generic, so prior authorization is common, especially if a cheaper testosterone could work.
Run your own numbers with our TRT cost calculator, and see how telehealth, clinic, and insurance routes stack up in how much does TRT cost.
How Do You Find a Clinic That Prescribes Natesto?
Not every TRT provider stocks Natesto or knows the fertility playbook. A men's health urologist or a reproductive endocrinologist is more likely to be fluent in it than a general anti-aging clinic.
When you're vetting a provider, ask:
- Do you have experience prescribing Natesto specifically for fertility preservation?
- Will you run a baseline semen analysis before I start, and again during treatment?
- How will you monitor LH, FSH, testosterone, PSA, and hematocrit?
- What's your plan if I want to start trying for a child?
- Can you help with HCG or enclomiphene if Natesto alone isn't enough?
A clinic that shrugs at the fertility question or pushes pellets on a young man who wants kids is the wrong fit. Browse vetted options on our providers directory and use how to choose a TRT provider to separate the legit clinics from the supplement mills. If you're going the online route, best online TRT clinics breaks down what good telehealth looks like.
Whatever you choose, fertility-friendly TRT only works if you confirm it's working. Get a baseline semen analysis, check your hormones on a schedule, and don't assume. Our TRT blood work guide lays out the full monitoring calendar.
The Bottom Line
Natesto is a niche tool that does one job better than anything else on the market: it raises testosterone while protecting your ability to have kids. The biology is sound, the trial data is consistent, and roughly 90% to 95% of men in studies kept normal semen parameters, against up to 65% azoospermia on standard TRT.
It's not free of trade-offs. Three doses a day, nasal irritation, a steep cash price, and a label limited to true hypogonadism all narrow the fit. But for the right man, a younger guy with low testosterone who isn't done having children, Natesto can be the difference between treating his symptoms and protecting his future. Talk it through with a clinician who understands both testosterone and fertility before you decide.
Frequently Asked Questions
Does Natesto really not affect fertility? It affects it far less than standard TRT. In the Phase IV trial, most men kept normal semen parameters and only 1 of 60 became azoospermic, and he recovered after stopping (Ramasamy 2020, PMID 32294396). It's "fertility-friendly," not guaranteed. You should still get a semen analysis before and during use.
How fast does Natesto raise testosterone? Quickly, but briefly. Testosterone peaks around 40 minutes after a dose, then falls over the next few hours. That fast rise-and-fall is exactly why it spares fertility. For how symptom relief builds over weeks, see our TRT results timeline.
Can I use Natesto if I have allergies or a stuffy nose? Sometimes, but with caution. Allergic rhinitis cut testosterone absorption by 21% to 24% in label data, and the FDA advises against use in men with chronic nasal conditions or recent nasal surgery. A bad cold may mean pausing doses until it clears. Talk to your clinician.
Is Natesto better than testosterone injections? Better for fertility, yes. For convenience, no, injections are once or twice a week versus three times a day for Natesto. The right answer depends on your goals. See subcutaneous vs intramuscular injections and our delivery methods guide.
Will insurance cover Natesto? Often only with prior authorization, since it's a brand-name drug with no generic. Many men use the manufacturer savings card or a GoodRx coupon to bring the price down. Check current pricing on GoodRx and estimate your total with our TRT cost calculator.
Related Guides
- TRT & Fertility: HCG and Enclomiphene Explained
- Enclomiphene vs TRT: A Fertility-Friendly Alternative
- TRT Delivery Methods: Injections vs Cream vs Pellets vs Nasal
- How to Choose a TRT Provider
- TRT Blood Work: The Labs & Monitoring Schedule
References
- Ramasamy R, et al. Effect of Natesto on Reproductive Hormones, Semen Parameters and Hypogonadal Symptoms: A Single Center, Open Label, Single Arm Trial. J Urol. 2020. PMID 32294396
- Masterson T, et al. Natesto Effects on Reproductive Hormones and Semen Parameters: Results from an Ongoing Single-center, Investigator-initiated Phase IV Clinical Trial. Eur Urol Focus. 2018. PMID 30177402
- Hashimi MA, et al. Clinician's guide to the management of azoospermia induced by exogenous testosterone or anabolic-androgenic steroids. Asian J Androl. 2025. PMID 39820213
- Coviello AD, et al. Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. J Clin Endocrinol Metab. 2005. PMID 15713727
- Hsieh TC, et al. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy. J Urol. 2013. PMID 23260550
- Kim ED, et al. Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men, unlike topical testosterone: restoration instead of replacement. BJU Int. 2016. PMID 26496621
- Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018. PMID 29562364
- Natesto (testosterone) nasal gel, prescribing information. FDA / DailyMed. Label
- Natesto pricing. GoodRx, 2026. goodrx.com/natesto